Original Research
Accepted on 30 Dec 2025
Comparative cost-effectiveness of Sintilimab, Toripalimab, and Camrelizumab in first-line therapy for advanced non-squamous non-small cell lung cancer
in Health Economics
Frontiers in Public Health
Type at least 3 characters
1,811 articles
articles
Original Research
Accepted on 29 Dec 2025
Global trends, decomposition analysis, inequality assessment, and economic projections of tracheal, bronchus, and lung cancer
in Health Economics
Frontiers in Public Health
Original Research
Accepted on 29 Dec 2025
On Quality Standards and the Timing of Pharmaceutical Investment
in Health Economics
Frontiers in Public Health
Original Research
Accepted on 24 Dec 2025
Impact of digital economy on residents' medical cost: An empirical analysis based on interprovincial data from China
in Health Economics
Frontiers in Public Health
Original Research
Published on 24 Dec 2025
Comparative study: mapping treatment costs, best practices, and challenges across Africa
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1690239
- 594 views
Brief Research Report
Accepted on 22 Dec 2025
Unlocking Economic Gains: The Impact of Image-Guided Brachytherapy on Cervical Cancer Treatment in Thailand
in Health Economics
Frontiers in Public Health
Original Research
Accepted on 22 Dec 2025
Cost-Utility Analysis of Telitacicept versus Belimumab in the Treatment of Systemic Lupus Erythematosus in China
in Health Economics
Frontiers in Public Health
- 101 views
General Commentary
Accepted on 22 Dec 2025
Commentary: What Have We Learnt About the Sourcing of Personal Protective Equipment During Pandemics? Leadership and Management in Healthcare Supply Chain Management: A Scoping Review
in Health Economics
Frontiers in Public Health
- 193 views
Correction
Published on 19 Dec 2025
Correction: Spatio-temporal patterns and determinants of persistent catastrophic health expenditure in China: evidence from the China Family Panel Studies
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1761344
- 355 views
Original Research
Accepted on 18 Dec 2025
Nivolumab Plus Ipilimumab versus lenvatinib or sorafenib for US and Chinese Patients with unresectable hepatocellular carcinoma: A cost-effectiveness analysis
in Health Economics
Frontiers in Public Health
- 153 views
Original Research
Published on 18 Dec 2025
Availability, price and affordability of anticancer medicines in Jiangsu Province, China: a cross-sectional survey study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1729325
- 475 views
Original Research
Published on 18 Dec 2025
Economic value of AI-based MRI triage for Parkinson’s disease: a cost-benefit study in South Korea and the United States
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1723829
- 724 views
Original Research
Published on 18 Dec 2025
Comorbidity and cost burden among ischemic stroke inpatients aged 60 years and older in middle-high-income region in China: a multicenter cross-sectional study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1692057
- 460 views
Original Research
Accepted on 16 Dec 2025
The Law of Diminishing Marginal Returns in Health Insurance: Evidence on Child Health Outcomes from Pakistan's Sehat Sahulat Program
in Health Economics
Frontiers in Public Health
- 162 views
Original Research
Accepted on 16 Dec 2025
Cost of illness analysis in individuals with overweight or obesity and chronic low back pain in the Bern metropolitan area (The BO2WL trial)
in Health Economics
Frontiers in Public Health
Original Research
Published on 16 Dec 2025
An analysis of cost-saving in the German statutory health insurance system due to the introduction of epoetin alfa biosimilars in Germany
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1667315
- 383 views
Systematic Review
Accepted on 15 Dec 2025
Efficacy, Safety, and Costs of Nine Chinese Patent Medicines for the Treatment of angina pectoris in CHD
in Health Economics
Frontiers in Public Health
- 123 views
Original Research
Accepted on 15 Dec 2025
Model-based economic evaluation of pharmacopuncture for chronic low back pain: a three-year Markov analysis
in Health Economics
Frontiers in Public Health
- 114 views
Original Research
Accepted on 15 Dec 2025
When the Cure Leaks: Corruption, Health Spending, and Health Outcomes in Malawi
in Health Economics
Frontiers in Public Health
- 104 views
Perspective
Accepted on 15 Dec 2025
Addressing the need for economic modelling when designing and reporting a diagnostic testing accuracy study
in Health Economics
Frontiers in Public Health
Review
Accepted on 15 Dec 2025
Measuring the Health Benefits of Genome and Exome Sequencing: A Systematic Review of Economic Evaluations
in Health Economics
Frontiers in Public Health
Original Research
Published on 15 Dec 2025
Treatment preferences in low-risk papillary thyroid microcarcinoma: a discrete choice experiment
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1686729
- 453 views
Original Research
Published on 11 Dec 2025
Characteristics of hospitalization patterns and expenditures in cross-border medical tourism: a knee replacement surgery cohort study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1655280
- 518 views
Correction
Published on 11 Dec 2025
Correction: Knowledge, attitudes, and practices regarding China's DRG payment policy among healthcare professionals in tertiary and secondary hospitals in Yunnan Province: a cross-sectional study
in Health Economics
Frontiers in Public Health
doi 10.3389/fpubh.2025.1741985
- 224 views